Fifth diseasehttps://en.wikipedia.org/wiki/Fifth_disease
Fifth disease ke e 'ngoe ea lipontšo tse ngata tse ka bang teng tsa tšoaetso ka parvovirus B19. Fifth disease e atile haholo baneng.

Fifth disease e qala ka feberu ea boemo bo tlase, hlooho e opang, lekhopho, le matšoao a kang a serame, joalo ka nko e tsubellang kapa e koetsoeng. Matšoao ana a feta, ebe matsatsi a seng makae hamorao, lekhopho le hlaha. Hangata lekhopho le bofubelu bo khanyang le hlaha sefahlehong, haholo-holo marameng. (ka hona lebitso "lefu la marama le shapuoa"). Ho phaella marameng a mafubelu, bana ba atisa ho ba le lekhopho le lefubelu le lacy 'meleng kaofela, moo matsoho a ka holimo, sethoto le maoto e leng libaka tse tloaelehileng haholo.

Hangata lefu lena ha le bonolo, empa ho basali ba bakhachane, tšoaetso ka trimester ea pele e amahanngoa le hydrops fetalis, e bakang ho senyeheloa ke mpa ka tšohanyetso.

Kalafo
Ha ho hlokahale phekolo e khethehileng kaha hangata e ntlafala ha nako e ntse e ea.

☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • 16-months old with Fifth disease ― Marama ka bobeli a fetoha a mafubelu, joalokaha eka oa shapuoa, 'me makhopho a maculopapular a hlaha' meleng.
  • Erythema marameng ka bobeli.
  • 'Mele o ka boela oa tsamaea le lekhopho le hlahang.
  • Ena ke lekhopho le hlahang marameng a linaha tse peli le bakoang ke tšoaetso ea kokoana-hloko ea B19.
References Fifth disease (parvovirus B19) 35951969 
NIH
Fifth disease , e tsejoang hape e le erythema infectiosum, ke tšoaetso ea kokoana-hloko e bakoang ke human parvovirus B19. E atile haholo baneng, hangata e ama ba pakeng tsa lilemo tse 4 ho isa ho tse 14. Hangata matšoao a qala ka feberu e seng matla, hlooho e opang, 'metso le maikutlo a kang a ntaramane. Bana ba ka 'na ba e-ba le lekhopho le lefubelu sefahlehong le tšoanang le slapped cheeks , hammoho le lekhopho 'meleng, matsoho le maoto. Ho batho ba baholo, bohloko ba manonyeletso ke tletlebo e tloaelehileng, e ka hlahang libeke ka mor'a tšoaetso ea pele. Ka ho hlakileng, hoo e ka bang karolo ea 20 ho isa ho 30 lekholong ea batho ba baholo ba tšoaelitsoeng ke parvovirus B19 ba ka 'na ba se be le matšoao leha e le afe.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
 Exposure to fifth disease in pregnancy 20008596 
NIH
Kotsi ea ho feta parvovirus B19 ho tloha ho 'm'a ho ea ho lesea e ka ba 33%, 'me hoo e ka bang 3% ea basali ba nang le tšoaetso ba ba le mathata maseeng a bona. Ha 'm'e a tšoaetsoa pele ho libeke tse 20 tsa bokhachane, menyetla ea mathata a kang mathata a mali le ho bokellana ha mokelikeli 'meleng oa lesea ho eketseha. Ho qala ho laola lefu lena, re lokela ho hlahloba hore na mokuli o kile a pepesehela parvovirus ka ho hlahloba li-antibodies tse itseng (IgM) . Haeba tlhahlobo e sa bontše ho pepeseha ha nako e fetileng empa e bontša tšoaetso ea morao-rao, mokuli o hloka ho behoa leihlo haufi-ufi nakong ea bokhachane, ho kenyelletsa le lisebelisoa tse tloaelehileng tsa ultrasound ho hlahloba mathata a itseng a bophelo bo botle ba lesea.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.